Biogen Stock Drops as Earnings and Guidance Disappoint
Biogen’s new CEO, Christopher Viehbacher, said the company is well positioned to return to sustainable growth.
Source: marketwatch.com
4523 To News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from 4523 To. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In 4523 To Today - Breaking & Trending Today
Biogen Ends Development of Alzheimer's Drug Aduhelm
Biogen will record a one-time charge of about $60 million related to close-out costs of the program.
Source: marketwatch.com
Biogen Reports Earnings Wednesday. Here's What to Expect.
When Biogen reports earnings Wednesday, investors won’t be paying much attention to the numbers. Biogen is in a period of cost-cutting, and trying to build...
Source: marketwatch.com
Biogen and Eisai's Injected Alzheimer's Drug Works, but Safety Questions Linger
Wall Street analysts say Biogen and Eisai could secure Food and Drug Administration approval for their injected Alzheimer’s drug.
Source: marketwatch.com
Merck, Eisai: Keytruda/Lenvima Combo Fails in Head, Neck Cancer Study
By Colin Kellaher Merck & Co. and Eisai are ending a late-stage study of the cancer drugs Keytruda plus Lenvima in patients with certain types of...
Source: marketwatch.com